Damage control surgery of the critical Jehovah?s Witness patient-a narrative review

被引:0
|
作者
Naicker, Y. D. [1 ]
Ahmed, N. [1 ]
Davids, R. [1 ]
机构
[1] Stellenbosch Univ, Tygerberg Hosp, Combined Crit Care Unit, Stellenbosch, South Africa
关键词
damage control surgery; Jehovah?s Witness; trauma-related injuries; BLOOD-LOSS; TOURNIQUET USE; SOUTH-AFRICA; DESMOPRESSIN; TRANSFUSION; HYPOTENSION;
D O I
10.36303/SAJS.3874
中图分类号
R61 [外科手术学];
学科分类号
摘要
South Africa has a high burden of trauma related injuries with haemorrhage remaining a leading treatable complication of trauma. Expedient management of haemorrhage serves to reduce patient morbidity and mortality. Damage control surgery aims to minimise haemorrhage, contain contamination, and allow restoration of physiology in an intensive care unit (ICU) before proceeding to definitive surgery. Over time, damage control surgery has found favour in non-trauma -related surgeries in unstable patients. The Jehovah's Witness (JW) religion believes that blood is sacred and strictly do not consent to blood or blood product transfusions, including in emergency settings. Thus, the management of a bleeding or bled-out JW patient proves to be a unique challenge in modern medicine. For the JW patient who is undergoing damage control surgery, the primary goal is to win time for recovery of the haemoglobin level by maintaining adequate oxygen delivery to tissues. We review the multiple methods available to optimise haemodynamic stability in a bleeding JW patient. These include techniques aimed at (i) minimising blood loss, (ii) optimising oxygen delivery (DO2), (iii) optimising oxygen consumption (VO2), and (iv) correction of coagulopathy. The management of haemorrhage in the JW patient remains challenging. It is imperative for healthcare professionals to be aware of all options available when treating these patients in order to provide optimal treatment whilst maintaining respect for their beliefs.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
  • [31] Chemotherapy, erythropoietin and bloodless surgery in a Jehovah's Witness
    Brown, JE
    Hatton, MQ
    Melchers, R
    Goldstraw, P
    Coleman, RE
    CLINICAL ONCOLOGY, 2003, 15 (07) : 371 - 377
  • [32] Cell salvage in the Jehovah's Witness patient - Response
    Booke, M
    ANESTHESIA AND ANALGESIA, 2000, 90 (01): : 230 - 230
  • [33] Management of Placenta Previa in a Jehovah's Witness Patient
    Srinivasan, Aariya
    Ikram, Jibran
    Ayad, Sabry
    CLINICAL CASE REPORTS, 2024, 12 (12):
  • [34] Acquired haemophilia A in a patient who is a Jehovah's Witness
    Brown, Clare
    Page, Andrew
    BMJ CASE REPORTS, 2022, 15 (08)
  • [35] Uterine artery embolisation in a Jehovah's Witness patient
    de Jong, Peter
    van der Schyff, Malika
    SAJOG-SOUTH AFRICAN JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 12 (03): : 160 - 162
  • [36] The child Jehovah's Witness patient: A legal and ethical dilemma
    Groudine, SB
    SURGERY, 1997, 121 (03) : 357 - 358
  • [37] Use of erythropoietin for bloodless surgery in a Jehovah's witness infant
    Pérez-Ferrer, A
    De Vicente, J
    Gredilla, E
    García-Vega, MI
    Bourgeois, P
    Goldman, LJ
    PAEDIATRIC ANAESTHESIA, 2003, 13 (07): : 633 - 636
  • [38] URO-ONCOLOGIC SURGERY IN JEHOVAH'S WITNESS PATIENTS
    Jones, L.
    Deane, L.
    JOURNAL OF ENDOUROLOGY, 2009, 23 : A96 - A96
  • [39] The Jehovah's Witness family, transfusions, and pediatric day surgery
    Morrison, JE
    Lane, G
    Kelly, S
    Stool, S
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 1997, 38 (03) : 197 - 205
  • [40] Elective splenectomy in an anemic Jehovah's Witness patient with cirrhosis
    Pivalizza, EG
    Tjia, IM
    Juneja, HS
    Cohen, AM
    Duke, JH
    ANESTHESIA AND ANALGESIA, 1998, 87 (03): : 529 - 530